BCRX — BIOCRYST PHARMACEUTICALS INC
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on BCRX
| date | signal | measured base rate |
|---|---|---|
| 2026-08-14 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-08-12 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-31 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-07-13 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-06-25 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-25 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-11 | HEGGIE THERESA Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-06-11 | Stonehouse Jon P Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-06-11 | MILANO VINCENT Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-06-11 | McKee Amy E Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-06-11 | Frank Steven Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-06-11 | LEVIN ALAN G Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-06-11 | Galson Steven K Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-06-11 | Milne Jill C. Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-06-11 | SANDERS MACHELLE Director | Grant or award | 15.3K | 0.00 | 0 |
| 2026-05-29 | Frank Steven Director | Grant or award | 1.3K | 8.91 | 11.2K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 215.6M | 22.7M |
| RA CAPITAL MANAGEMENT, L.P. | 150.7M | 15.8M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 143.2M | 15.0M |
| STATE STREET CORP | 116.2M | 12.2M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 107.0M | 11.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 106.0M | 11.1M |
| TCG Crossover Management, LLC | 104.9M | 11.0M |
| JANUS HENDERSON GROUP PLC | 84.9M | 8.9M |
| PERCEPTIVE ADVISORS LLC | 70.8M | 7.4M |
| Vestal Point Capital, LP | 66.9M | 7.0M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about BCRX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →